MX2020012265A - Goma de mascar en tabletas adecuada para ingredientes farmaceuticos activos. - Google Patents
Goma de mascar en tabletas adecuada para ingredientes farmaceuticos activos.Info
- Publication number
- MX2020012265A MX2020012265A MX2020012265A MX2020012265A MX2020012265A MX 2020012265 A MX2020012265 A MX 2020012265A MX 2020012265 A MX2020012265 A MX 2020012265A MX 2020012265 A MX2020012265 A MX 2020012265A MX 2020012265 A MX2020012265 A MX 2020012265A
- Authority
- MX
- Mexico
- Prior art keywords
- chewing gum
- active pharmaceutical
- pharmaceutical ingredients
- particles
- tableted chewing
- Prior art date
Links
- 229940112822 chewing gum Drugs 0.000 title abstract 3
- 235000015218 chewing gum Nutrition 0.000 title abstract 3
- 239000008186 active pharmaceutical agent Substances 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 5
- 150000005846 sugar alcohols Chemical class 0.000 abstract 2
- 229920001971 elastomer Polymers 0.000 abstract 1
- 239000000806 elastomer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/08—Chewing gum characterised by the composition containing organic or inorganic compounds of the chewing gum base
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8188—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bonds, and at least one being terminated by a bond to sulfur or by a hertocyclic ring containing sulfur; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/982,772 US11096895B2 (en) | 2018-05-17 | 2018-05-17 | Oral tablet suitable for active pharmaceutical ingredients |
| US15/986,362 US11090263B2 (en) | 2018-05-22 | 2018-05-22 | Tableted chewing gum suitable for active pharmaceutical ingredients |
| PCT/DK2019/050157 WO2019219147A1 (en) | 2018-05-17 | 2019-05-15 | A tableted chewing gum suitable for active pharmaceutical ingredients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020012265A true MX2020012265A (es) | 2021-01-29 |
Family
ID=66820994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020012265A MX2020012265A (es) | 2018-05-17 | 2019-05-15 | Goma de mascar en tabletas adecuada para ingredientes farmaceuticos activos. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3787604B1 (https=) |
| JP (1) | JP7214755B2 (https=) |
| KR (1) | KR102697867B1 (https=) |
| CN (1) | CN112118831B (https=) |
| AU (1) | AU2019268497B2 (https=) |
| BR (1) | BR112020022379A2 (https=) |
| CA (1) | CA3097953C (https=) |
| ES (1) | ES2951848T3 (https=) |
| MX (1) | MX2020012265A (https=) |
| RU (1) | RU2770035C1 (https=) |
| WO (1) | WO2019219147A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11096894B2 (en) | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Oral tablet for induced saliva generation |
| US10933017B2 (en) | 2019-03-01 | 2021-03-02 | Nordiccan A/S | Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers |
| US11253473B2 (en) | 2019-03-01 | 2022-02-22 | Nordiccan A/S | Method of producing tableted cannabinoid chewing gum |
| US11471405B2 (en) | 2019-03-01 | 2022-10-18 | Nordiccan A/S | Tableted chewing gum with enhanced delivery of cannabinoids |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US12439952B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Moist oral compositions |
| WO2021116842A1 (en) * | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Oral products with controlled release |
| US12520867B2 (en) | 2019-12-09 | 2026-01-13 | Nicoventures Trading Limited | Buffered oral compositions |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| US12433321B2 (en) | 2019-12-09 | 2025-10-07 | Nicoventures Trading Limited | Oral composition with beet material |
| US12310959B2 (en) | 2019-12-09 | 2025-05-27 | Nicoventures Trading Limited | Oral compositions with reduced water content |
| US11969502B2 (en) | 2019-12-09 | 2024-04-30 | Nicoventures Trading Limited | Oral products |
| US11617744B2 (en) | 2019-12-09 | 2023-04-04 | Nico Ventures Trading Limited | Moist oral compositions |
| US12439949B2 (en) | 2019-12-09 | 2025-10-14 | Nicoventures Trading Limited | Oral compositions with reduced water activity |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| EP4146166A1 (en) * | 2020-05-08 | 2023-03-15 | Fertin Pharma A/S | Mouthwash for oral care benefits |
| MX2023015529A (es) | 2021-06-25 | 2024-03-05 | Nicoventures Trading Ltd | Productos orales y metodo de fabricacion. |
| DK202330231A1 (en) * | 2023-09-27 | 2025-04-10 | Fertin Pharma As | Cannabidiol for alleviating xerostomia |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3070510A (en) | 1959-11-03 | 1962-12-25 | Procter & Gamble | Dentifrice containing resinous cleaning agents |
| US3538230A (en) | 1966-12-05 | 1970-11-03 | Lever Brothers Ltd | Oral compositions containing silica xerogels as cleaning and polishing agents |
| US3862307A (en) | 1973-04-09 | 1975-01-21 | Procter & Gamble | Dentifrices containing a cationic therapeutic agent and improved silica abrasive |
| US4340583A (en) | 1979-05-23 | 1982-07-20 | J. M. Huber Corporation | High fluoride compatibility dentifrice abrasives and compositions |
| US4997654A (en) * | 1989-08-14 | 1991-03-05 | Warner-Lambert Company | Method for increasing salivation for xerostomia patients |
| JP3122141B2 (ja) * | 1994-01-31 | 2001-01-09 | 山之内製薬株式会社 | 口腔内溶解型圧縮成型物及びその製造法 |
| US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
| US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| WO2000025598A1 (en) | 1998-11-03 | 2000-05-11 | Dandy A/S | Sucrose fatty acid esters for use as increased release of active ingredients |
| US6350480B1 (en) * | 1999-12-30 | 2002-02-26 | Wm. Wrigley Jr. Company | Chewing gum product including a hydrophilic gum base and method of producing |
| JP2004520389A (ja) * | 2001-02-08 | 2004-07-08 | ファルマシア・コーポレーション | 性的不全の治療のための早期効果発現薬剤 |
| SE0102197D0 (sv) * | 2001-06-20 | 2001-06-20 | Pharmacia Ab | New product and use and manufacture thereof |
| WO2006063189A2 (en) * | 2004-12-10 | 2006-06-15 | Novartis Ag | Multi-layered chewing gum tablet with quick disintegration layer |
| RU2391856C2 (ru) * | 2005-12-16 | 2010-06-20 | Вм. Ригли Дж. Компани | Жевательная резинка в оболочке |
| CN101563069B (zh) * | 2006-08-04 | 2012-07-11 | 爱的发 | 多层口服崩解片 |
| JP5766899B2 (ja) * | 2007-04-11 | 2015-08-19 | ニプロ株式会社 | 口腔内崩壊剤及びその製造方法 |
| WO2009080023A1 (en) * | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum comprising peptide |
| US9511021B2 (en) * | 2008-05-21 | 2016-12-06 | Novartis, A.G. | Tablettable chewing gums |
| WO2010019689A2 (en) * | 2008-08-14 | 2010-02-18 | Wm. Wrigley Jr. Company | Confectionery products providing an increased hydration sensation |
| EP2793849A1 (en) * | 2011-12-22 | 2014-10-29 | Fertin Pharma A/S | Method of releasing nicotine from chewing gum |
| WO2013171164A1 (en) * | 2012-05-14 | 2013-11-21 | EJP Pharmaceutical ApS | Compositions and formulations for the treatment of halitosis |
| CA2978517A1 (en) * | 2014-03-04 | 2015-09-11 | Eastgate Pharmaceuticals Inc. | Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof |
| FR3023128B1 (fr) * | 2014-07-01 | 2017-11-10 | Roquette Freres | Nouvelle composition edulcorante |
| BR112019007798B1 (pt) * | 2016-11-18 | 2023-12-19 | Fertin Pharma A/S | Comprimido com veículo de liberação oral |
| CN110087634A (zh) * | 2016-11-18 | 2019-08-02 | 费丁制药联合股份有限公司 | 提供口腔护理有益效果的方法 |
-
2019
- 2019-05-15 BR BR112020022379-4A patent/BR112020022379A2/pt unknown
- 2019-05-15 AU AU2019268497A patent/AU2019268497B2/en active Active
- 2019-05-15 CN CN201980032268.4A patent/CN112118831B/zh active Active
- 2019-05-15 CA CA3097953A patent/CA3097953C/en active Active
- 2019-05-15 EP EP19729615.5A patent/EP3787604B1/en active Active
- 2019-05-15 KR KR1020207031894A patent/KR102697867B1/ko active Active
- 2019-05-15 JP JP2020564437A patent/JP7214755B2/ja active Active
- 2019-05-15 RU RU2020141413A patent/RU2770035C1/ru active
- 2019-05-15 WO PCT/DK2019/050157 patent/WO2019219147A1/en not_active Ceased
- 2019-05-15 MX MX2020012265A patent/MX2020012265A/es unknown
- 2019-05-15 ES ES19729615T patent/ES2951848T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020022379A2 (pt) | 2021-02-02 |
| KR20210013551A (ko) | 2021-02-04 |
| EP3787604A1 (en) | 2021-03-10 |
| AU2019268497B2 (en) | 2022-01-06 |
| CA3097953C (en) | 2023-09-12 |
| WO2019219147A1 (en) | 2019-11-21 |
| CN112118831B (zh) | 2023-04-21 |
| CN112118831A (zh) | 2020-12-22 |
| RU2770035C1 (ru) | 2022-04-14 |
| JP7214755B2 (ja) | 2023-01-30 |
| JP2021524442A (ja) | 2021-09-13 |
| EP3787604B1 (en) | 2023-07-05 |
| ES2951848T3 (es) | 2023-10-25 |
| EP3787604C0 (en) | 2023-07-05 |
| CA3097953A1 (en) | 2019-11-21 |
| AU2019268497A1 (en) | 2020-10-22 |
| KR102697867B1 (ko) | 2024-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020012265A (es) | Goma de mascar en tabletas adecuada para ingredientes farmaceuticos activos. | |
| MX2024008539A (es) | Compuestos bifuncionales para degradar la tirosina cinasa de bruton (btk) mediante la trayectoria de ubiquitina proteosoma. | |
| MX2022007084A (es) | Composicion liquida para uso oral o para uso en un dispositivo de entrega de aerosol. | |
| EP4570320A3 (en) | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway | |
| JOP20220020B1 (ar) | مثبطات kars تعتمد على akr1c3 ثلاثية الحلقة | |
| PH12022550359A1 (en) | Nonpeptide somatostatin type 5 receptor agonists and uses thereof | |
| NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
| JOP20190193B1 (ar) | ممركبات 2-أريل غير متجانس-3-أكسو-2، 3-ثنائي هيدرو بيريدازين-4-كربوكساميد لمعالجة السرطان | |
| ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
| EP4461369A3 (en) | Aerosolized compositions comprising mitochondria and methods of use thereof | |
| ATE302616T1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
| NO20045072L (no) | Tablett med hoyt medikamentinnhold | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| EP4289423A3 (en) | An oral cannabinoid tablet | |
| MX2020012280A (es) | Tableta oral para la generacion de saliva inducida. | |
| EP3773900A4 (en) | HINOKITIOL ANALOGUES, PROCESSES FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| UA86622C2 (ru) | Фармацевтическая композиция, которая диспергируется в ротовой полости, для введения в слизистую оболочку ротовой полости или подъязычного введения агомелатина | |
| MX2022004523A (es) | Formulaciones de liberacion controlada para sustancias fisiologicamente activas altamente lipofilicas. | |
| FI20080548A7 (fi) | Essitalopraamiemästä sisältäviä, suussa hajoavia tabletteja ja menetelmä niiden valmistamiseksi | |
| TR201914406A2 (tr) | Sapropteri̇n di̇hi̇droklorür ve en az bi̇r farmasöti̇k eksi̇pi̇yan i̇çeren kati oral farmasöti̇k formülasyonlar | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| EA200701503A2 (ru) | Твердая пероральная лекарственная форма триметазидина дигидрохлорида с пролонгированным высвобождением, способ ее получения и способ лечения | |
| ECSP21079422A (es) | Método para preparar formulaciones de péptidos estables | |
| PL431521A1 (pl) | Kompozycja wspomagająca mineralizację zębów w postaci tabletki pudrowej | |
| CO2020006552A2 (es) | Composiciones farmaceuticas que comprenden safinamida |